Wells Fargo’s Phio Pharmaceuticals PHIO Stock Holding History

Wells Fargo’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2	Closed	-$13	–	7323
2024 Q1	$13	Hold	2	–	–	﹤0.01%	7237
2023 Q4	$14	Hold	2	–	–	﹤0.01%	7315
2023 Q3	$24	Buy	2 +1	+100%	+$21	﹤0.01%	7141
2023 Q2	$32	Hold	1	–	–	﹤0.01%	7181
2023 Q1	$45	Hold	1	–	–	﹤0.01%	7137
2022 Q4	$35	Hold	1	–	–	﹤0.01%	7119
2022 Q3	$0	Hold	1	–	–	﹤0.01%	7188
2022 Q2	$0	Buy	+1	New	+$94	﹤0.01%	7314
2022 Q1	–	Hold	0	–	–	–	7627
2021 Q4	–	Hold	0	–	–	–	7661
2021 Q3	–	Sell	-1	Closed	-$209	–	7371
2021 Q2	$0	Buy	+1	New	+$246	﹤0.01%	7301
2021 Q1	–	Hold	0	–	–	–	7253
2020 Q4	–	Hold	0	–	–	–	6875
2020 Q3	–	Hold	0	–	–	–	6743
2020 Q2	–	Hold	0	–	–	–	6680
2020 Q1	–	Hold	0	–	–	–	6644
2017 Q2	–	Hold	0	–	-$3K	–	6394
2017 Q1	–	Hold	0	–	–	–	6116
2016 Q2	–	Hold	0	–	–	–	6266
2016 Q1	–	Hold	0	–	–	–	6371
2015 Q4	–	Hold	0	–	–	–	6367
2015 Q3	–	Hold	0	–	–	–	6384
2015 Q2	–	Hold	0	–	–	–	6473
2015 Q1	–	Hold	0	–	–	–	6305
2014 Q4	–	Hold	0	–	–	–	6354
2014 Q3	–	Hold	0	–	–	–	6299
2014 Q2	–	Hold	0	–	–	–	6242
2014 Q1	–	Hold	0	–	–	–	6026

Other funds holding PHIO

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Wells Fargo's PHIO Position: Q2 2024 in Review

Wells Fargo sold out of Phio Pharmaceuticals (PHIO) in Q2 2024, closing a stake of 2 shares — an estimated $13 sold.

Wells Fargo first reported a position in PHIO in Q2 2021 and held it in 9 quarters. The position peaked at $45 in Q1 2023. 11 funds tracked by Wall St. Rank hold PHIO as of Q2 2024.

Wells Fargo reported no remaining Phio Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Wells Fargo sold 2 Phio Pharmaceuticals shares in Q2 2024, an estimated $13.
Wells Fargo first reported a position in Phio Pharmaceuticals in Q2 2021 and held it in 9 quarters.
Wells Fargo's Phio Pharmaceuticals position peaked at $45 in Q1 2023.
11 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.